IMPACT OF POLYCYSTIC OVARY SYNDROME ON QUALITY OF LIFE OF WOMEN IN EARLY REPRODUCTIVE AGE

2018 ◽  
Vol 14 (66) ◽  
pp. 087
Author(s):  
L. V. Pakharenko ◽  
I. T. Kyshakevych ◽  
V. D. Vorobii
2019 ◽  
Vol 7 (3) ◽  
pp. 42
Author(s):  
Hanan Elzeblawy Hassan ◽  
Doaa Shehta Said Farg

Background: Polycystic ovary syndrome (PCOS) is an uncertain etiology heterogeneous disorder, which affects 6.0% to 10.0% of women in their reproductive age. Aim: assess phenotypic characteristics of women with PCOS, discovery the association between women’s quality-of-life (QOL) and its occurrence and improve women’s knowledge & increase awareness regarding PCOS.Methods: A descriptive cross-sectional design had been utilized on a purposive sample of 300 women in reproductive age with PCOS in the gynecological outpatient clinic at Beni-Suef General Hospital, Egypt. A structured interviewing schedule, patient’s assessment record, visual-analogue-scale, Ferriman-Gallwey-Evaluation-of-Hirsutism, QOL Questionnaire, Short-Form-Health-Survey (SF-36), and designed intervention nursing-guideline had been used for data collection.Results: A high percentage (56.7%) of women had a complete phenotype characteristics of PCOS. The most prevalent phenotypic characteristics were alopecia (65.0%), irregular menses (58.7%), and obesity/overweight (48.1%). Statistically significant was found between women’s general characteristic of PCOS and their age, body-mass-index, hirsutism, and average cycle length, p < .05. Women’s QOL had affected negatively by PCO Syndrome, p < .05.Conclusions: PCOS is a common risk factor for acne, alopecia, hirsutism. Many factors to be associated with its phenotype as: body-mass-index, hirsutism, and average cycles length. It has a negative impact on phenotype characteristic, psychological/social domain and total QOL scale. The nursing guideline had a crucial role in the improvement of women’s knowledge in allover items of women’s knowledge.Recommendation: Upgrading women’s knowledge concerning PCOS with a periodic screening of women for early detection and management. Health-Promotion-Programs through different media to improve QOL for women with PCOS.


2020 ◽  
Vol 14 ◽  
pp. 263349412091103 ◽  
Author(s):  
Yvonne V. Louwers ◽  
Joop S.E. Laven

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age. It is a complex disease in which genetic, endocrine, environmental, and behavioral factors are intertwined, giving rise to a heterogeneous phenotype with reproductive, metabolic, and psychological characteristics. Polycystic ovary syndrome affects women’s health and their quality of life across the life course. During different life stages, the polycystic ovary syndrome phenotype can change, which requires a personalized diagnostic approach and treatment. Polycystic ovary syndrome is a major cause of anovulatory infertility; this disorder is also associated with hirsutism and acne. Diagnosing polycystic ovary syndrome during adolescence is challenging because the polycystic ovary syndrome criteria include normal physiological events that occur during puberty. With increasing age, the syndrome evolves from a reproductive disease to a more metabolic disorder. Along with metabolic disturbances, including insulin resistance and abnormalities of energy expenditure, polycystic ovary syndrome is recognized as a major risk factor for the development of type 2 diabetes and cardiovascular disease in later life. Moreover, there is evidence for familial clustering of endocrine and metabolic features of polycystic ovary syndrome. Environmental factors such as diet and obesity appear to contribute to the phenotype. Treatment should be tailored to the specific concerns and needs of the individual patient and involves restoring fertility, treatment of the metabolic complaints, treatment of androgen excess, and providing endometrial protection. The complexity of the disorder, and the impact on quality of life, requires a timely diagnosis, screening for complications, and management strategies for the long-term health issues associated with polycystic ovary syndrome. The syndrome remains underdiagnosed, and women experience significant delays to diagnosis.


2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Magdalena Derewianka-Polak ◽  
Grzegorz Polak ◽  
Joanna Tkaczuk-Włach ◽  
Aneta Gerhant ◽  
Marcin Olajossy

Abstract Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women at the reproductive age. In 2018, the European Society of Human Reproduction and Embryology (ESHRE) developed and published new accurate recommendations for the diagnosis and management of women with PCOS. In this work, a separate chapter is devoted to the quality of life and mental disorders in patients with polycystic ovary syndrome. Material and Methods: This article provides an overview of the literature regarding mental disorders associated with PCOS with the focus on the ESHRE recommendations. Conclusion: The medical staff and patients should be aware of the negative impact of polycystic ovary syndrome on the quality of life, coexistence of depression, anxiety, psychosexual and eating disorders.


Author(s):  
Ewa Rzońca ◽  
Agnieszka Bień ◽  
Artur Wdowiak ◽  
Ryszard Szymański ◽  
Grażyna Iwanowicz-Palus

2010 ◽  
Vol 94 (5) ◽  
pp. 1812-1816 ◽  
Author(s):  
Rebecca L. Thomson ◽  
Jonathan D. Buckley ◽  
Siew S. Lim ◽  
Manny Noakes ◽  
Peter M. Clifton ◽  
...  

2018 ◽  
Vol 5 (2) ◽  
pp. 205510291878819 ◽  
Author(s):  
Sophie Williams ◽  
David Sheffield ◽  
Rebecca C Knibb

Polycystic ovary syndrome is an endocrine disorder amongst women, which can negatively impact quality of life. Research proposes that a more sensitive PCOS quality of life measure is needed. This study aims to develop and initially validate a quality of life scale for women with the condition in the United Kingdom. Women with PCOS (n = 714) took part in the development and initial validation of the 35-item polycystic ovary syndrome quality of life scale (PCOSQOL)(α = .95). Subscales include Impact of PCOS (α = .95), Infertility (α = .95), Hirsutism (α = .97) and Mood (α = .89). The PCOSQOL scale represents aspects of quality of life important to women with PCOS and may be more sensitive for use in the clinical and research settings.


Medicine ◽  
2019 ◽  
Vol 98 (50) ◽  
pp. e18323 ◽  
Author(s):  
Romilson de Lima Nunes ◽  
Isis Kelly dos Santos ◽  
Ricardo Ney Cobucci ◽  
Gabriel Soares Pichini ◽  
Gustavo Mafaldo Soares ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document